top of page

Search

Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th

Oct 31, 2024
1 min read

Click here to learn more and register!

Recent Posts

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Advocate for Change Join the Massachusetts Biomarker Testing Coalition Lobby Day, NEXT WEEK May 13th

Advocate for Change Join the Massachusetts Biomarker Testing Coalition Lobby Day, NEXT WEEK May 13th

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

Comments

bottom of page